Target intelligence / Profile preview

Novel transcript antisense to alcohol dehydrogenase 4, alcohol dehydrogenase 6, and alcohol dehydrogenase 1A (LOC100507053 (also ENSG00000246090))

Target
LOC100507053 (also ENSG00000246090)
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

LOC100507053 (ENSG00000246090) is classified as a long non-coding RNA (lncRNA) that acts as a natural antisense transcript to the genes alcohol dehydrogenase 4 (ADH4), alcohol dehydrogenase 6 (ADH6), and alcohol dehydrogenase 1A (ADH1A). Its specific molecular function remains uncharacterized, but as an antisense transcript, it is hypothesized to function as a local regulator of gene expression, potentially modulating the expression of genes involved in processes such as secretion, metabolism, fibroblast activation, and the maintenance of tissue barriers[1][3][5]. There is no evidence to suggest it functions directly as a receptor, enzyme, or classical therapeutic target. Its role is currently understood to be in RNA-based regulation rather than as a protein-coding gene. It is not commonly referenced as a disease biomarker, pharmacological target, or safety concern.

Other names
ENSG00000246090LOC100507053novel transcript antisense to ADH4, ADH6 & ADH1A
02

Biological functions

Regulation of gene expression (likely in cis and/or trans)Putative local regulation of genes involved in fibroblast activation, secretion, metabolism, or maintenance of tissue barriers
03

Disease associations

Other (possible association with gastric diseases, but evidence unclear)

Beyond the preview

Go deeper on Novel transcript antisense to alcohol dehydrogenase 4, alcohol dehydrogenase 6, and alcohol dehydrogenase 1A (LOC100507053 (also ENSG00000246090)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript antisense to alcohol dehydrogenase 4, alcohol dehydrogenase 6, and alcohol dehydrogenase 1A (LOC100507053 (also ENSG00000246090)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call